Biomarker Research
Biomarker Research(英文缩写 BIOMARK RES),ISSN 2050-7771,eISSN 2050-7771 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-09-21 至 2026-09-21，按本站收录文献的发表日期统计。
指标来源：jcr_cas_ifqb
期刊简介
暂无简介。
Biomarker Research 最新收录文献
-
1. Metabolic-inflammatory index CTI identifies high-risk early-stage natural killer/T-cell lymphoma and informs a novel prognostic model.
PMID:作者:日期:2026-09-16The prognostic heterogeneity of early-stage natural killer/T-cell lymphoma (NKTCL) remains inadequately defined. This study aimed to investigate the prognostic value and potential biological relevance of the metabolic-inflammatory biomarkers in early-stage NKTCL. We conducted a secondary analysis on…
-
2. Biohybrid M13 phage backpacks for active blood-brain barrier traversal and precision central nervous system leukemia treatment.
PMID:作者:日期:2026-09-16Central nervous system (CNS) leukemia remains a major clinical challenge in acute lymphoblastic leukemia, largely due to the restrictive nature of the blood-brain barrier (BBB), which severely limits therapeutic delivery and contributes to high relapse rates and poor prognosis. Here, we report ALB-p…
-
3. Cellular crosstalk of fibroblast-myofibroblast transition in intestinal homeostasis and disease.
PMID:作者:日期:2026-09-16Fibroblasts are central components of the intestinal microenvironment and can acquire a myofibroblast phenotype through fibroblast-to-myofibroblast transition (FMT), a process linked to increased tissue mechanosensitivity and active extracellular matrix (ECM) remodeling. In this way, FMT participate…
-
4. Beyond hypoxia and ccRCC: the expanding universe of VHL novel targets and next-generation therapeutics.
PMID:作者:日期:2026-09-09The von Hippel-Lindau (VHL) gene encodes the core substrate-recognition subunit of the Cullin2-RING E3 ubiquitin ligase complex, regulating cellular oxygen sensing and proteostasis. While targeting the canonical VHL-hypoxia-inducible factor (HIF) axis (e.g. belzutifan) has improved advanced clear ce…
-
5. AI-driven precision immunotherapy: emerging trends from AACR 2026.
PMID:作者:日期:2026-09-09Artificial intelligence (AI) has become a pivotal driver of innovation in cancer immunotherapy through large-scale biological data modeling, multimodal information integration, and advanced machine learning approaches. At the AACR Annual Meeting 2026, AI-based frameworks demonstrated broad applicati…
-
6. Inflammatory bone marrow microenvironment impairs the therapeutic effect of daratumumab-lenalidomide in multiple myeloma.
PMID:作者:日期:2026-09-05Daratumumab-lenalidomide (DR) combination therapy improves multiple myeloma (MM) outcomes, yet some patients respond poorly. We examined 21 DR pre-treatment samples from the IFM2017-03 phase 3 trial using single-cell and bulk multiomics approaches to identify determinants of response. Analysis of th…
-
7. Integrating molecular subtypes, genomics and functional dependencies to identify context-specific therapeutic vulnerabilities in small cell lung cancer.
PMID:作者:日期:2026-09-05Small cell lung cancer is one of the most aggressive malignancies, characterized by rapid tumor growth, early metastatic spread and extremely poor survival. Although most patients initially respond to platinum-based chemotherapy, relapse is almost inevitable and treatment options at recurrence remai…
-
8. Mapping brain volume changes in the zQ175DN mouse model of Huntington's disease: a longitudinal MRI study.
PMID:作者:日期:2026-09-01Huntington's disease (HD) is a progressive neurodegenerative disease affecting motor and cognitive abilities, as well as exhibiting psychiatric manifestations. Studies in people with HD (PwHD) consistently report atrophy of the caudate and putamen as an early pathological event and is therefore cons…
-
9. Evaluating global clinical trials and development trends of antibody-drug conjugates.
PMID:作者:日期:2026-08-28Antibody-drug conjugates (ADCs) represent a breakthrough in tumor-targeted therapy, showing promise in both solid tumors and hematological malignancies. By 1 September 2025, more than 370 ADC candidates had entered clinical development, 17 unique products had received at least one regulatory approva…
-
10. Intra-aortic balloon pump use and in-hospital mortality in acute myocardial infarction with Killip class III or IV: a nationwide cohort study.
PMID:作者:日期:2026-08-26The intra-aortic balloon pump (IABP) remains widely used in acute myocardial infarction (AMI) complicated by severe heart failure or shock, particularly where access to advanced mechanical circulatory support is limited. Contemporary nationwide evidence in AMI presenting with Killip class III or IV …